share_log

中國中藥：董事會會議召開日期

TRAD CHI MED: DATE OF BOARD MEETING

香港交易所 ·  Mar 11 05:02
Summary by Moomoo AI
中國中藥控股有限公司（「本公司」）將於2024年3月21日（星期四）召開董事會會議，主要議程為考慮及批准截至2023年12月31日止年度的末期業績及其發佈，並討論派發末期股息的可能性。該會議將由包括執行董事陳映龍先生、程學仁先生及楊文明先生，非執行董事李茹女士等，以及獨立非執行董事謝榮先生等在內的十一名董事參與。會議的結果將對投資者的利益產生重要影響，特別是關於末期股息的決策。
中國中藥控股有限公司（「本公司」）將於2024年3月21日（星期四）召開董事會會議，主要議程為考慮及批准截至2023年12月31日止年度的末期業績及其發佈，並討論派發末期股息的可能性。該會議將由包括執行董事陳映龍先生、程學仁先生及楊文明先生，非執行董事李茹女士等，以及獨立非執行董事謝榮先生等在內的十一名董事參與。會議的結果將對投資者的利益產生重要影響，特別是關於末期股息的決策。
CHINA PHARMACEUTICAL HOLDINGS LIMITED (THE “COMPANY”) WILL HOLD A BOARD MEETING ON THURSDAY, MARCH 21, 2024. THE MAIN AGENDA IS TO CONSIDER AND APPROVE THE FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 AND THEIR RELEASE, AND TO DISCUSS THE POSSIBILITY OF DISTRIBUTING A FINAL DIVIDEND. The meeting will be attended by eleven directors, including Executive Directors Mr. Chen Ying Lung, Mr. Ching Shu Yan and Mr. Yang Man Ming, Non-Executive Director Ms. Li Ju, etc., and Independent Non-Executive Director Mr. Tse Wing. The outcome of the meeting will have a significant impact on the interests of investors, in particular decisions regarding the final dividend.
CHINA PHARMACEUTICAL HOLDINGS LIMITED (THE “COMPANY”) WILL HOLD A BOARD MEETING ON THURSDAY, MARCH 21, 2024. THE MAIN AGENDA IS TO CONSIDER AND APPROVE THE FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 AND THEIR RELEASE, AND TO DISCUSS THE POSSIBILITY OF DISTRIBUTING A FINAL DIVIDEND. The meeting will be attended by eleven directors, including Executive Directors Mr. Chen Ying Lung, Mr. Ching Shu Yan and Mr. Yang Man Ming, Non-Executive Director Ms. Li Ju, etc., and Independent Non-Executive Director Mr. Tse Wing. The outcome of the meeting will have a significant impact on the interests of investors, in particular decisions regarding the final dividend.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more